request an appointment online.
- Diagnosis & Treatment
- Cancer Types
- Prostate Cancer
Get details about our clinical trials that are currently enrolling patients.
View Clinical TrialsProstate cancer is a type of cancer that starts in the prostate, a walnut-sized gland in the male reproductive system that helps produce semen and nourishes sperm. Prostate cancer forms when cells in the prostate become abnormal and start rapidly multiplying.
Prostate cancer is a type of cancer that starts in the prostate, a walnut-sized gland in the male reproductive system that helps produce semen and nourishes sperm. Prostate cancer forms when cells in the prostate become abnormal and start rapidly multiplying.
The prostate sits just below the bladder and in front of the rectum. It surrounds part of the urethra, the tube that empties urine from the bladder.
The majority of prostate cancers are adenocarcinomas. 'Adenocarcinomas' refer to cancers that begin in the gland cells that help make up the lining of many organs, including the prostate.
Despite only impacting males, prostate cancer is the third most common cancer in the United States, with more than 191,000 new cases diagnosed each year. It is also one of the most treatable cancers, with a five-year survival rate of nearly 98%.
This success is due to a number of factors. The disease is often slow-growing; there are effective, established treatments; and most cases are caught before cancer has spread beyond the prostate, making the disease easier to treat.
Symptoms
Prostate cancer often shows no symptoms in the early stages. In more advanced prostate cancer, symptoms may appear. However, they can vary from person to person. Since the prostate is close to the bladder and surrounds the urethra, which empties the bladder, most symptoms involve urination.
Symptoms of prostate cancer may include:
- Inability to urinate or difficulty in starting to urinate
- Trouble emptying the bladder completely
- Weak or interrupted urine flow
- Painful or burning urination
- Difficulty trying to hold back urination
- Frequent or urgent need to urinate
- Blood in the urine or semen
- Difficulty having or maintaining an erection (erectile dysfunction or ED)
- Continual pain in the bones, including in the lower back, pelvis, hips, or thighs. This is typically only experienced by patients whose prostate cancer has spread to their bones (metastatic prostate cancer).
These symptoms do not always mean you have prostate cancer. Sometimes these symptoms may be related to benign prostatic hyperplasia (BPH), a non-cancerous condition in which the prostate increases in size and may cause urination problems. While BPH needs to be treated, it is not prostate cancer. Other non-cancerous conditions could also cause these symptoms, so it is important to discuss them with your doctor.
Risk factors
Anything that increases your chance of getting prostate cancer is a risk factor. These include:
- Age: This is the most important risk factor. More than 90% of cases are in men who are age 55 or older.
- Family history: Risk is higher when other members of your family (especially father, brother, son) have or had prostate cancer. The risk increases if your family member was diagnosed at a younger age. Learn more about family history and cancer.
- Hereditary cancer syndromes: Certain genetic mutations increase a man¡¯s risk of developing prostate cancer. These include Lynch syndrome and mutations of the BRCA1 and BRCA 2 genes. Learn more about hereditary cancer syndromes.
- Race: African American men or men of African descent have nearly double the risk of prostate cancer as white men. It is found less often in Asian American, Hispanic, and American Indian men.
- Diet: A high-fat diet, particularly a diet high in animal fats, may increase risk. Diets high in fruits and vegetables may decrease risk.
- Nationality: Prostate cancer is more prevalent in North America and northwestern Europe than in other parts of the world.
- Some research suggests that inflammation of the prostate (prostatitis) may play a role in prostate cancer. Sexually transmitted diseases are being investigated as possible risk factors as well.
Prevention
Certain actions may help lower your risk of prostate cancer:
- Eat at least five servings of fruits and vegetables daily and eat less red meat. Decrease fat intake.
- Tell your doctor about the supplements you take. Some of these may decrease the PSA level.
- Exercise regularly
- Maintain your ideal weight
Other ways to prevent prostate cancer are being investigated. These include:
- Lycopenes: These substances found in tomatoes, pink grapefruit and watermelon may help prevent damage to cells.
- Proscar? (finasteride) or Avodart? (dutasteride): These medications can reduce the risk of low-grade prostate cancer. If you are at high risk for prostate cancer, talk to your urologist or another provider who is familiar with studies about these drugs.
Some cases of prostate cancer can be passed down from one generation to the next. Genetic counseling may be right for you. Learn more about the risk to you and your family on our genetic testing page.
MD Anderson is #1 in Cancer Care
What to know about metastatic prostate cancer
Metastatic prostate cancer is prostate cancer that has spread outside of the prostate to other parts of the body. This is also known as stage IV disease.
At MD Anderson, I treat patients with advanced prostate cancer, most of whom have metastatic disease. A lot of our research is focused on how we can better treat metastatic prostate cancer to improve patients¡¯ results.
Here, I¡¯ll answer common questions I get about metastatic prostate cancer, including what MD Anderson is doing to advance treatment.
Where is prostate cancer most likely to spread?
Prostate cancer often spreads to the bones and lymph nodes. It most commonly spreads to bones in the pelvis or spine. Sometimes it spreads to the ribs.
Over time, prostate cancer can spread to other bones, such as the base of the skull. This is usually a sign of very advanced cancer.
How is metastatic prostate cancer treated?
We¡¯ve known since the 1940s that prostate cancer is a hormone-driven disease. Early studies showed that surgically removing the testes in men, which decreases the body¡¯s testosterone, led to improvement in prostate cancer ¨C temporarily, at least.
While we don¡¯t commonly perform those surgeries anymore, we continue to direct treatment at testosterone, the male sex hormone. Surgery is usually not an option for metastatic prostate cancer. At MD Anderson, we work together as a team of specialists to treat stage IV prostate cancer. Patients may receive:
Hormone therapy
Antiandrogens are medications that block the production of testosterone or stop their interaction with cancer cells.
Chemotherapy
Chemotherapy is often used to treat metastatic prostate cancer by destroying cancer cells.
Radiation therapy
Patients who have painful metastases in their bones may receive targeted radiation therapy to those areas.
Supportive care
We work closely with our Supportive Care team to help patients manage pain during treatment.
What is the survival rate for metastatic prostate cancer?
The average length of survival after a new, metastatic prostate cancer diagnosis is about 5 to 6 years. But it¡¯s important to remember that prostate cancer is not a one-size-fits-all disease. Survival rates are averages. Some patients will live longer than the average, and some will live less than the average. Speak with your doctor about your specific prognosis.
Metastatic prostate cancer goes through two phases, and this impacts the length of survival.
Hormone-sensitive prostate cancer
During this phase, treatments directed toward the testosterone hormones are working well to keep the cancer from growing.
Hormone-refractory prostate cancer
Prostate cancer is smart, and eventually, it learns how to grow without testosterone. This is what we call hormone-refractory, or castration-resistant, prostate cancer. On average, metastatic prostate cancer takes 2 to 3 years to become castration-resistant, but it could be longer or shorter depending on the features of the cancer. Once the disease reaches this phase, average survival is another 2 to 3 years.
What are the latest advances in metastatic prostate cancer treatment?
There is a lot of exciting research happening right now. We¡¯re focusing on identifying specific biomarkers to help us select the right treatment for each patient.
In 2022, the approved a targeted nuclear medicine therapy called lutetium Lu 177 vipivotide tetraxetan to treat prostate-specific membrane antigen (PSMA) metastatic castration-resistant prostate cancer. It targets the PSMA protein and delivers radiation to those cancer cells.
We have PSMA PET scans that look for PSMA in cancer cells. If the prostate cancer makes this protein, the patient is a good fit for PSMA-targeted treatment. A showed that patients who received lutetium Lu 177 vipivotide tetraxetan lived longer than those in the control arm who received a different treatment. So, we have a new treatment option to offer patients. Eligible patients receive the treatment as an infusion every six weeks.
At MD Anderson, we¡¯re also conducting clinical trials to study how immunotherapy can help treat prostate cancer. Prostate cancer historically hasn¡¯t seen the same success with immunotherapy as other cancers, like melanoma or lung cancer. We¡¯re hoping to change that.
What¡¯s your best advice for men who¡¯ve been diagnosed with advanced prostate cancer and their loved ones?
I always tell people that one of the key reasons for coming to MD Anderson is the wealth of clinical trial opportunities we offer. Of course, there are pros and cons, but that is a conversation we have with each patient.
If you have been diagnosed with prostate cancer, specifically metastatic prostate cancer, I strongly encourage you to ask your oncologist about clinical trials. Ask them, ¡®What¡¯s new in the pipeline? What other options beyond the standard treatment do we potentially have?¡¯
We haven¡¯t cured metastatic prostate cancer yet. But we¡¯re moving in the right direction.
, is a genitourinary medical oncologist at MD Anderson who specializes in treating advanced prostate cancer.
or call 1-877-632-6789.
Why choose MD Anderson for your prostate cancer treatment?
Choosing the right hospital may be the most important decision you make as a prostate cancer patient. At MD Anderson you¡¯ll get care and support from one of the nation¡¯s top-ranked cancer centers.
Here, you can benefit from the expertise at our Multidisciplinary Prostate Clinic. Most newly diagnosed patients with intermediate to high-risk prostate cancer have a choice between surgery or radiation therapy. During your first clinic visit you will have a joint appointment with a radiation oncologist and surgeon who both specialize in prostate cancer. The three of you will review your case and discuss your treatment options. Your doctors may even discuss clinical trials with you, which could offer better outcomes than standard treatments.
If you have a more complex cancer, such as a disease that has recurred or spread, we offer the most advanced therapies. Thanks to our robust research and clinical trial programs, these may include new surgical options or new cancer drugs, such as targeted therapy or immunotherapy.
And at MD Anderson you'll also be surrounded by the strength of one of the nation's largest and most experienced cancer centers. From a dedicated prostate cancer support group to counseling to integrative medicine care, we have all the services needed to treat not just the disease, but the whole person.
None of us really knew what to expect, but MD Anderson has been incredible, from the second my parents walked through its doors. Everyone they¡¯ve dealt with there has been both welcoming and helpful.
Collin McHugh
Caregiver
Treatment at MD?Anderson
Prostate cancer is treated in our Genitourinary Center and our Proton Therapy Center.
Featured Articles

Prostate cancer survivor excited to donate blood again

Prostate cancer survivor grateful for high-intensity focused ultrasound (HIFU)

What are the top 5 warning signs of prostate cancer?

Prostate cancer survivor: MD Anderson is the only place to be

Two-time cancer survivor grateful for a second opinion and MD Anderson

Finding care and compassion at MD Anderson through multiple cancer diagnoses

Prostate cancer survivor: I¡¯m grateful for treatment at MD Anderson

How retzius-sparing prostatectomy helped a prostate cancer patient
Clinical Trials
MD Anderson patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
?
Becoming Our Patient
Get information on patient appointments, insurance and billing, and directions to and around MD Anderson.
myCancerConnection
Talk to someone who shares your cancer diagnosis and be matched with a survivor.
?
Prevention & Screening
Many cancers can be prevented with lifestyle changes and regular screening.
?
Counseling
MD Anderson has licensed social workers to help patients and their loved ones cope with cancer.
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.?